ATE330956T1 - Bizyklisch substituierte 4- aminopyridopyrimidinderivate - Google Patents

Bizyklisch substituierte 4- aminopyridopyrimidinderivate

Info

Publication number
ATE330956T1
ATE330956T1 AT02252428T AT02252428T ATE330956T1 AT E330956 T1 ATE330956 T1 AT E330956T1 AT 02252428 T AT02252428 T AT 02252428T AT 02252428 T AT02252428 T AT 02252428T AT E330956 T1 ATE330956 T1 AT E330956T1
Authority
AT
Austria
Prior art keywords
substituted
bizyclic
aminopyridopyrimidine
derivatives
compounds
Prior art date
Application number
AT02252428T
Other languages
English (en)
Inventor
Samit Kumar Bhattacharya
John Charles Kath
Joel Morris
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE330956T1 publication Critical patent/ATE330956T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT02252428T 2001-04-13 2002-04-03 Bizyklisch substituierte 4- aminopyridopyrimidinderivate ATE330956T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28391001P 2001-04-13 2001-04-13

Publications (1)

Publication Number Publication Date
ATE330956T1 true ATE330956T1 (de) 2006-07-15

Family

ID=23088090

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02252428T ATE330956T1 (de) 2001-04-13 2002-04-03 Bizyklisch substituierte 4- aminopyridopyrimidinderivate

Country Status (9)

Country Link
US (1) US6927220B2 (de)
EP (1) EP1249451B1 (de)
JP (1) JP4028278B2 (de)
AT (1) ATE330956T1 (de)
BR (1) BR0201286A (de)
CA (1) CA2381513C (de)
DE (1) DE60212487T2 (de)
ES (1) ES2263743T3 (de)
MX (1) MXPA02003796A (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636195A1 (de) * 2003-05-27 2006-03-22 Pfizer Products Inc. Chinazoline und pyrido[3,4-d]pyrimidine als rezeptor tyrosin kinase inhibitoren
UA96745C2 (en) * 2005-11-22 2011-12-12 Кудос Фармасьютикалз Лимитед PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
US8030495B2 (en) * 2007-05-23 2011-10-04 Coleman Paul J Cyclopropyl pyrrolidine orexin receptor antagonists
EP2638036B1 (de) * 2010-11-09 2017-08-16 Betta Pharmaceuticals Co., Ltd. Verbindung zur erhöhung der kinaseaktivität und ihre verwendung
AU2020328598B2 (en) 2019-08-15 2026-07-02 Black Diamond Therapeutics, Inc. Alkynyl quinazoline compounds
CA3175102A1 (en) * 2020-03-13 2021-09-16 Suzhou Zanrong Pharma Ltd. Erbb receptor inhibitors as anti-tumor agents
TW202309022A (zh) 2021-04-13 2023-03-01 美商努法倫特公司 用於治療具egfr突變之癌症之胺基取代雜環
WO2022266458A1 (en) * 2021-06-17 2022-12-22 Black Diamond Therapeutics, Inc. 6-heterocycloalkyl-quinazoline derivatives and uses thereof

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884418B1 (en) 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
US6177401B1 (en) * 1992-11-13 2001-01-23 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
CA2223081C (en) * 1995-06-07 2001-03-06 Pfizer Inc. Heterocyclic ring-fused pyrimidine derivatives
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
CN100503580C (zh) 1996-04-12 2009-06-24 沃尼尔·朗伯公司 酪氨酸激酶的不可逆抑制剂
AR007855A1 (es) 1996-07-13 1999-11-24 Glaxo Group Ltd Compuestos heterociclicos fusionados como inhibidores de proteina tirosina quinasa, sus metodos de preparacion, intermediarios, uso en medicinay composiciones farmaceuticas que los contienen
HRP970371A2 (en) * 1996-07-13 1998-08-31 Kathryn Jane Smith Heterocyclic compounds
SK6652000A3 (en) * 1997-11-11 2002-05-09 Pfizer Prod Inc Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
RS49779B (sr) 1998-01-12 2008-06-05 Glaxo Group Limited, Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze
GB9800575D0 (en) 1998-01-12 1998-03-11 Glaxo Group Ltd Heterocyclic compounds
GB2345486A (en) 1999-01-11 2000-07-12 Glaxo Group Ltd Heteroaromatic protein tyrosine kinase inhibitors
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
JP3270834B2 (ja) * 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
US6297238B1 (en) * 1999-04-06 2001-10-02 Basf Aktiengesellschaft Therapeutic agents
JP2003504363A (ja) 1999-07-09 2003-02-04 グラクソ グループ リミテッド プロテインチロシンキナーゼ阻害剤としてのアニリノキナゾリン類
US20050038047A1 (en) * 2003-08-14 2005-02-17 Edwards Paul John Azaquinazoline derivatives

Also Published As

Publication number Publication date
US6927220B2 (en) 2005-08-09
EP1249451A3 (de) 2003-03-12
CA2381513C (en) 2006-01-10
DE60212487T2 (de) 2006-12-21
JP4028278B2 (ja) 2007-12-26
JP2002322178A (ja) 2002-11-08
ES2263743T3 (es) 2006-12-16
MXPA02003796A (es) 2002-11-07
CA2381513A1 (en) 2002-10-13
EP1249451A2 (de) 2002-10-16
DE60212487D1 (de) 2006-08-03
US20030045535A1 (en) 2003-03-06
EP1249451B1 (de) 2006-06-21
BR0201286A (pt) 2003-03-11

Similar Documents

Publication Publication Date Title
EA200600892A1 (ru) Новые хинолиновые производные
EA200500814A1 (ru) Производные пирролопиримидина
PT1029853E (pt) Derivados biciclicos heteroaromaticos uteis como agentes anticancerigenos
MXPA06002296A (es) Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos.
WO2004020431A3 (en) Novel benzoimidazole derivatives useful as antiproliferative agents
EA200100135A1 (ru) Алкинилзамещенные производные хинолин-2-она, полезные в качестве противораковых агентов
SE9904176D0 (sv) New use
MY139571A (en) Indolyl derivatives as liver-x-receptor modulators
DOP2001000170A (es) Derivados de tiofeno utiles como agentes anticancesoros
ATE440603T1 (de) 8-hydroxychinolinderivate
SE9903760D0 (sv) New compounds
MXPA05006420A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal.
PT928788E (pt) Compostos farmaceuticamente activos
EA200000391A1 (ru) Производные тиенопиримидина и тиенопиридина, полезные в качестве противораковых агентов
SG128491A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
ATE399171T1 (de) Camptothecinanaloge und deren zubereitungsmethoden
EA200201277A1 (ru) Замещенные бициклические производные для лечения аномального роста клеток
WO2003074529A3 (en) iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
NO20055143L (no) Doseringsformer innbefattende AG013736
WO2005066167A3 (en) 3-quinuclidinyl heteroatom bridged biaryl derivatives
DE69709493D1 (de) Substituierte Indazolderivate
YU94103A (sh) Novi derivati sulfonske kiseline
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
IL169184A0 (en) Aromatic compounds as anti-inflammatory, immunomdulatory and anti-proliferatory agents
NO20052730L (no) Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties